key: cord-0951181-skcl2owx authors: Ma, Xixiang; Guan, Chuhuai; Chen, Rong; Wang, Yunyun; Feng, Shenglei; Wang, Rongshuai; Qu, Guoqiang; Zhao, Sijia; Wang, Fengli; Wang, Xiaoli; Zhang, Dingyu; Liu, Liang; Liao, Aihua; Yuan, Shuiqiao title: Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients date: 2020-12-14 journal: Cell Mol Immunol DOI: 10.1038/s41423-020-00604-5 sha: 83652519fa83a1f8fcb1fb06b9c6cb817000aebc doc_id: 951181 cord_uid: skcl2owx nan indicate that SARS-CoV-2 infection may impair male GC development and eventually lead to GC loss. SARS-CoV-2 can induce cellular and humoral immune changes and destroy antiviral immunity at an early stage in COVID-19 patients. 4, 5 To ascertain how male GC loss occurs in patients with COVID-19, we investigated the presence of apoptosis and inflammatory reactions in the testicular cells. TUNEL assays revealed that the number of apoptotic cells in COVID-19 testes was significantly higher than that in control testes ( Supplementary Fig. S1e, f) , raising the possibility that SARS-CoV-2 damages the immune privilege and innate immune homeostasis of the testis. Indeed, immunohistochemical (IHC) staining for various immune cells revealed scattered infiltration of CD3 + T lymphocytes, CD20 + B lymphocytes, and CD68 + macrophages in the interstitial compartments of patients with COVID-19, whereas such infiltration was rarely detected in controls ( Fig. 1b-d) . In addition, we found CD38 + (activated B cells) and CD138 + (plasma cells) cells in the interstitial compartments of COVID-19 patient testes (Supplementary Fig. S2a, b) . Correspondingly, extensive IgG precipitation was observed mainly in the seminiferous epithelium, interstitium, and some degenerated GCs, similar to the findings in SARS-infected testes (Fig. 1e) . 6 These data suggest that SARS-CoV-2 might trigger a secondary autoimmune response and contribute to the primary pathogenesis of viral orchitis and consequent testicular damage. To further determine whether SARS-CoV-2 can directly attack testicular cells, we first detected the nucleic acid sequence of SARS-CoV-2 in the testes of COVID-19 patients. Through RT-qPCRbased virus nucleic acid detection, we found two testis samples (patients 1 and 3) to be positive for SARS-CoV-2 nucleic acid (Supplementary Table S2 ). To further confirm the presence of the virus, we examined the testes from COVID-19 patients by immunohistochemistry using an anti-SARS-CoV spike S1 antibody. As shown in Fig. 1f , the testicular sections from patients stained positively, indicating infection of testicular cells by SARS-CoV-2. (Fig. 1f ) and suggesting that SARS-CoV-2 indeed infects testicular cells through the spike glycoprotein binding mechanism. Further transmission electron microscopy (TEM) analyses revealed coronavirus-like particles in the interstitial compartment of the testes of COVID-19 patients ( Fig. 1g and Supplementary Fig. S2c) , providing direct evidence that SARS-CoV-2 enters and attacks human testicular tissues. The SARS-CoV-2 spike protein binds to the angiotensinconverting enzyme 2 (ACE2) receptor through its receptorbinding domain. In turn, ACE2 employs the serine protease TMPRSS2 to activate the S protein, allowing its HR1 and HR2 domains to interact with each other and form a six-helical bundle (6-HB) to mediate membrane fusion between the virus and a target cell. 7-9 Therefore, we next examined the protein and mRNA levels of ACE2 and TMPRSS2 in the testes. Although both ACE2 and TMPRSS2 proteins were predominantly expressed in the cytoplasm and membrane of spermatocytes, spermatids, and Sertoli cells in control testes, elevated ACE2 and TMPRSS2 levels were observed in the seminiferous tubules of all patients with COVID-19 ( Fig. 1h and Supplementary Fig. S3a, b) . Consistent with the immunohistochemistry results, RT-qPCR showed significantly increased mRNA levels of ACE2 and TMPRSS2 in the testes of all COVID-19 patient compared to control patient testes (Fig. 1i, j) . Together, these results indicate that the signal intensity of ACE2-and TMPRSS2-positive cells in the testes of patients with COVID-19 is higher than that in the testes of uninfected controls, which further supports the hypothesis that SARS-CoV-2 is able to attack testicular cells. However, it is not clear how SARS-CoV-2 interferes with ACE2 and TMPRSS2 expression and/or their regulation. Some common diseases (COVID-19 comorbidities) are reported to be related to ACE2 expression, 10 and it is possible that higher levels of ACE2 and TMPRSS2 are observed in COVID-19 patient testes because patients with severe COVID-19 are more susceptible to SARS-CoV-2 due to underlying disease or individual differences in ACE2 and TMPRSS2 expression. To investigate the molecular changes associated with SARS-CoV-2 infection in testes, we extracted total RNA from control (controls 1, 2, and 3) and COVID-19 patient (patients 1, 2, and 3) testes and performed RNA-seq to analyze transcriptome changes. The analysis revealed 28,801 expressed coding RNAs and lncRNAs in control and COVID-19 patient testes (Supplementary Table S3) , of which 2645 were upregulated and 2789 were downregulated in COVID-19 patients compared with controls (fold change > 2, FDR < 0.001) (Fig. 1k, Supplementary Fig. S4a and Table S4 ). These results suggest that SARS-CoV-2 infection triggers dynamic transcriptome alterations at the molecular level in testes during specific biological processes. To further characterize changes in the transcriptome upon SARS-CoV-2 infection in the testes, we performed Gene Ontology term analysis of the differentially regulated genes. Consistent with our virus RNA detection and IHC results, the upregulated transcripts were significantly enriched in terms related to virus invasion, such as "viral gene expression" and "viral life cycle" (Supplementary Fig. S4b) . Importantly, some inflammation-related processes were activated, including the "interleukin-6-mediated signaling pathway" and "regulation of B-cell proliferation". Consistent with our histological results (Fig. 1a) , the downregulated genes were significantly enriched in "spermatogenesis" and "reproduction" (Supplementary Fig. S4c) , further illustrating the impact of SARS-CoV-2 infection on male fertility. Moreover, we found 32 inflammatory cytokines to be considerably upregulated, with a P value < 0.05 and fold change > 2, in COVID-19 patient testes, and 10 of these cytokines (CMTM6, FAM3C, INHBA, IL33, TNFSF10 , NAMPT, CMTM4, CCL28, IL2, and TIMP1) were significantly upregulated with an FDR < 0.001 (Supplementary Fig. S4d ). These bioinformatics data suggest that SARS-CoV-2 infection may lead to dysfunction of the genes that regulate spermatogenesis and inflammation-related pathways, thereby causing inflammatory immune attack in the testes and defects in spermatogenesis. Collectively, our findings provide direct evidence that SARS-CoV-2 can infect the testis and GCs, indicating the potential impact of the COVID-19 pandemic on spermatogenesis and male fertility. Nevertheless, further study is essential to reveal the underlying mechanism of SARS-CoV-2 infection of testicular cells and the correlation of testis infection with the clinical course of COVID-19. The RNA-seq data have been submitted to the NCBI GEO database (PRJNA661970). No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019 Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients Clinical characteristics and results of semen tests among men with coronavirus disease 2019 Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients Functional exhaustion of antiviral lymphocytes in COVID-19 patients Orchitis: a complication of severe acute respiratory syndrome (SARS) Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Impact of comorbidities on SARS-CoV-2 viral entry-related genes We thank the patients and their families for their dedication to help others understand this disease. We are also grateful for the support of the clinical staff and technicians for performing the autopsy work. The online version of this article (https://doi.org/10.1038/s41423-020-00604-5) contains supplementary material.Competing interests: The authors declare no competing interests.